Validus Pharmaceuticals

Wood Creek Capital Acquire NPC Products Rights in US with Acquire
Nov 27, 2012
Validus Pharmaceuticals and Wood Creek Capital Management have acquired the US rights to six product lines from Novartis Pharmaceuticals Corporation (NPC). The acquired six product lines include Lopressor (metoprolol tartrate USP) ...

Tags: Validus Pharmaceuticals, US rights, six product lines